(Q33331487)

English

Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys (English)

1 reference

Europe PubMed Central

25 July 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Sola MC

1

1 reference

Europe PubMed Central

25 July 2017

Christensen RD

2

1 reference

Europe PubMed Central

25 July 2017

Hutson AD

3

1 reference

Europe PubMed Central

25 July 2017

Tarantal AF

4

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 February 2000

1 reference

Europe PubMed Central

25 July 2017

Pediatric Research

1 reference

Europe PubMed Central

25 July 2017

47

1 reference

Europe PubMed Central

25 July 2017

2

1 reference

Europe PubMed Central

25 July 2017

208-214

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1203/00006450-200002000-00010

0 references

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Thrombocytopenia in the high-risk infant

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Frequency and mechanism of neonatal thrombocytopenia

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Clinical impact of neonatal thrombocytopenia

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Age-related differences in erythropoietic response to recombinant human erythropoietin: comparison in adult and infant rhesus monkeys

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Evaluation of the bioeffects of prenatal ultrasound exposure in the cynomolgus macaque (Macaca fascicularis): I. Neonatal/infant observations

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Hematologic and growth-related effects of frequent prenatal ultrasound exposure in the long-tailed macaque (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200002000-00010

21 January 2018

Identifiers

10.1203/00006450-200002000-00010

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33331487&oldid=2143964646"